PMID- 32534761 OWN - NLM STAT- MEDLINE DCOM- 20210224 LR - 20210224 IS - 0737-0806 (Print) IS - 0737-0806 (Linking) VI - 90 DP - 2020 Jul TI - Decellularization of Extracellular Matrix from Equine Skeletal Muscle. PG - 102962 LID - S0737-0806(20)30053-8 [pii] LID - 10.1016/j.jevs.2020.102962 [doi] AB - Equine represents an attractive animal model for musculoskeletal tissue diseases, exhibiting much similarity to the injuries that occur in humans. Cell therapy and tissue bioengineering have been widely used as a therapeutic alternative by regenerative medicine in musculoskeletal diseases. Thus, the aim of this study was to produce an acellular biomaterial of equine skeletal muscle and to evaluate its effectiveness in supporting the in vitro culture of equine induced pluripotency stem cells (iPSCs). Biceps femoris samples were frozen at -20 degrees C for 4 days and incubated in 1% sodium dodecyl sulfate (SDS), 5 mM EDTA + 50 mM Tris and 1% Triton X-100; the effectiveness of the decellularization was evaluated by the absence of remnant nuclei (histological and 4',6-diamidino-2-phenylindole [DAPI] analysis), preservation of extracellular matrix (ECM) proteins (immunofluorescence and immunohistochemistry) and organization of ECM ultrastructure (scanning electron microscopy). Decellularized samples were recellularized with iPSCs at the concentration of 50,000 cells/cm(2) and cultured in vitro for 9 days, and the presence of the cells in the biomaterial was evaluated by histological analysis and presence of nuclei. Decellularized biomaterial showed absence of remnant nuclei and muscle fibers, as well as the preservation of ECM architecture, vascular network and proteins, laminin, fibronectin, elastin, collagen III and IV. After cellularization, iPSC nuclei were present at 9 days after incubation, indicating the decellularized biomaterial-supported iPSC survival. It is concluded that the ECM biomaterial produced from the decellularized equine skeletal muscle has potential for iPSC adhesion, representing a promising biomaterial for regenerative medicine in the therapy of musculoskeletal diseases. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Miranda, Carla Maria Figueiredo de Carvalho AU - Miranda CMFC AD - Centre de recherche en reproduction et fertilite, Faculte de medecine veterinaire, Universite de Montreal, Saint-Hyacinthe, Quebec, Canada; Department of Surgery, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: carlacarvalhovet@gmail.com. FAU - Therrien, Jacinthe AU - Therrien J AD - Centre de recherche en reproduction et fertilite, Faculte de medecine veterinaire, Universite de Montreal, Saint-Hyacinthe, Quebec, Canada. FAU - Leonel, Luciano Cesar Pereira Campos AU - Leonel LCPC AD - Department of Surgery, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Sao Paulo, SP, Brazil. FAU - Smith, Olivia Eilers AU - Smith OE AD - Centre de recherche en reproduction et fertilite, Faculte de medecine veterinaire, Universite de Montreal, Saint-Hyacinthe, Quebec, Canada. FAU - Miglino, Maria Angelica AU - Miglino MA AD - Department of Surgery, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Sao Paulo, SP, Brazil. FAU - Smith, Lawrence Charles AU - Smith LC AD - Centre de recherche en reproduction et fertilite, Faculte de medecine veterinaire, Universite de Montreal, Saint-Hyacinthe, Quebec, Canada. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200319 PL - United States TA - J Equine Vet Sci JT - Journal of equine veterinary science JID - 8216840 RN - 0 (Biocompatible Materials) RN - 9002-93-1 (Octoxynol) RN - 9007-34-5 (Collagen) SB - IM MH - Animals MH - *Biocompatible Materials MH - Collagen MH - *Extracellular Matrix MH - Horses MH - Muscle, Skeletal MH - Octoxynol OTO - NOTNLM OT - Biomaterial OT - Decellularized extracellular matrix OT - Regenerative medicine OT - Skeletal muscle OT - iPSC EDAT- 2020/06/15 06:00 MHDA- 2021/02/25 06:00 CRDT- 2020/06/15 06:00 PHST- 2019/03/14 00:00 [received] PHST- 2019/07/17 00:00 [revised] PHST- 2020/02/06 00:00 [accepted] PHST- 2020/06/15 06:00 [entrez] PHST- 2020/06/15 06:00 [pubmed] PHST- 2021/02/25 06:00 [medline] AID - S0737-0806(20)30053-8 [pii] AID - 10.1016/j.jevs.2020.102962 [doi] PST - ppublish SO - J Equine Vet Sci. 2020 Jul;90:102962. doi: 10.1016/j.jevs.2020.102962. Epub 2020 Mar 19.